RADIORECEPTOR ASSAY FOR QUANTIFYING FK-506 IMMUNOSUPPRESSANT IN WHOLE-BLOOD

被引:0
|
作者
MURTHY, JN
CHEN, YJ
WARTY, VS
VENKATARAMANAN, R
DONNELLY, JG
ZEEVI, A
SOLDIN, SJ
机构
[1] CHILDRENS NATL MED CTR,DEPT LAB MED,111 MICHIGAN AVE NW,WASHINGTON,DC 20010
[2] GEORGE WASHINGTON UNIV,SCH MED,DEPT PATHOL,WASHINGTON,DC 20052
[3] GEORGE WASHINGTON UNIV,SCH MED,DEPT PHARMACOL,WASHINGTON,DC 20052
[4] GEORGE WASHINGTON UNIV,SCH MED,DEPT PEDIAT,WASHINGTON,DC 20052
[5] UNIV PITTSBURGH,SCH MED,DEPT PATHOL,PITTSBURGH,PA 15261
[6] UNIV PITTSBURGH,SCH PHARM,PITTSBURGH,PA 15260
关键词
IMMUNOSUPPRESSIVE DRUGS; FK-506 BINDING PROTEIN; ANTIBIOTICS;
D O I
暂无
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
We describe a quantitative radioreceptor assay (RRA) for quantifying FK-506 in whole blood. FK-506 extracted from whole blood with a cyclohexyl-sorbent column competes with [H-3]dihydro-FK-506 for binding to a partially purified preparation of FK-506 binding protein (FK-BP). Free and protein-bound FK-506 are separated on LH 20 Sephadex chromatographic columns. We compared the results of this method with those of an enzyme immunoassay that uses a monoclonal antibody: r = 0.97, S(y\x) = 0.039. Between-day precisions (CV) at FK-506 concentrations of 8 and 17-mu-g/L were 9.2% and 8.2%, respectively. Within-run precisions were 5.9%, 8.1%, and 9.4%, respectively, at 4, 8, and 15-mu-g/L. Analytical recovery, evaluated at 5, 10, 15, 20, and 25-mu-g/L for FK-506 added to whole blood, ranged from 98% to 103%. The assay can reliably quantify FK-506 blood concentrations between 1.0 and 25-mu-g/L.
引用
收藏
页码:1307 / 1310
页数:4
相关论文
共 50 条
  • [31] STABILITY OF FK506 (TACROLIMUS) IN WHOLE-BLOOD SPECIMENS
    INGELS, SC
    KOENIG, J
    SCOTT, MG
    CLINICAL CHEMISTRY, 1995, 41 (09) : 1320 - 1321
  • [32] THE SUPERIOR IMMUNOSUPPRESSANT ACCORDING TO DIAGNOSIS - FK-506 OR CYCLOSPORINE-A
    MUELLER, AR
    PLATZ, KP
    BLUMHARDT, G
    BECHSTEIN, WO
    STEINMULLER, T
    CHRISTE, W
    HOPF, U
    LOBECK, H
    NEUHAUS, P
    TRANSPLANTATION PROCEEDINGS, 1995, 27 (01) : 1117 - 1120
  • [33] AN IMMUNOSUPPRESSANT COMPOUND, FK-506, PREVENTS THE PROGRESSION OF AUTOIMMUNE MYOCARDITIS IN RATS
    HANAWA, H
    KODAMA, M
    ZHANG, SS
    IZUMI, T
    SHIBATA, A
    CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1992, 62 (03): : 321 - 326
  • [34] SYNTHESIS OF A C22-34 SUBUNIT OF THE IMMUNOSUPPRESSANT FK-506
    MARSHALL, JA
    XIE, SP
    JOURNAL OF ORGANIC CHEMISTRY, 1995, 60 (22): : 7230 - 7237
  • [35] HIGHLY PRACTICAL, ENANTIOSPECIFIC SYNTHESIS OF THE CYCLOHEXYL FRAGMENT OF THE IMMUNOSUPPRESSANT FK-506
    KOTSUKI, H
    NISHIKAWA, H
    MORI, Y
    OCHI, M
    JOURNAL OF ORGANIC CHEMISTRY, 1992, 57 (18): : 5036 - 5040
  • [36] ALLOGRAFT AND XENOGRAFT ACCEPTANCE UNDER FK-506 AND OTHER IMMUNOSUPPRESSANT TREATMENT
    STARZL, TE
    MURASE, N
    DEMETRIS, AJ
    ILDSTAD, S
    RICORDI, C
    TRUCCO, M
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1993, 685 : 46 - 51
  • [37] THE IMMUNOSUPPRESSANT FK-506 PREVENTS PROGRESSION OF DIABETES IN NONOBESE DIABETIC MICE
    KURASAWA, K
    KOIKE, T
    MATSUMURA, R
    TAKABAYASHI, K
    TOMIOKA, H
    ITO, I
    YOSHIDA, S
    CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1990, 57 (02): : 274 - 279
  • [38] WHOLE-BLOOD AND PLASMA-LEVELS OF FK-506 AFTER LIVER-TRANSPLANTATION - RESULTS FROM THE US MULTICENTER TRIAL
    BACKMAN, L
    LEVY, MF
    KLINTMALM, G
    TRANSPLANTATION PROCEEDINGS, 1995, 27 (01) : 1124 - 1124
  • [39] THERAPEUTIC EFFECT OF A NEW IMMUNOSUPPRESSANT, FK-506, ON VASOSPASM AFTER SUBARACHNOID HEMORRHAGE
    NISHIZAWA, S
    PETERSON, JW
    SHIMOYAMA, I
    IWASAKI, K
    UEMURA, K
    WEIR, BK
    CHYATTE, D
    NEUROSURGERY, 1993, 32 (06) : 986 - 992
  • [40] DISCOVERY OF FK-506, A NOVEL IMMUNOSUPPRESSANT ISOLATED FROM STREPTOMYCES-TSUKUBAENSIS
    GOTO, T
    KINO, T
    HATANAKA, H
    NISHIYAMA, M
    OKUHARA, M
    KOHSAKA, M
    AOKI, H
    IMANAKA, H
    TRANSPLANTATION PROCEEDINGS, 1987, 19 (05) : 4 - 8